Xevudy
Active substance: Sotrovimab
sotrovimab
Centralised EU authorisationWithdrawn
Marketing holder: GlaxoSmithKline Trading Services Limited
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/005676
- Registration status
- Withdrawn
- ATC code
- J06BD05
Sources
- product · EMA · EMEA/H/C/005676 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005676 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005676 · Verified 2026-10-09